MNT Weekly Delta — 2026-06-13

Molecular nanotechnology intelligence brief · Lookback window: Dec 2025 – Jun 2026 · Tiers: Demonstrated peer-reviewed/replicated · Reported preprint/single-source/company claim · Projected roadmap

First run. seen_items.md was empty, so this digest is a baseline rather than a true delta. Items below are scoped to the past ~6 months; a few high-profile pieces from mid/late 2025 (Leigh's catenane motor, Science Jul 2025; reconfigurable DNA-origami nanorobot arrays, Science Robotics Nov 2025) were checked and excluded as falling just outside the window. Future runs will report only newer items.

1. Summary

2. New technical developments

Mechanosynthesis / atomically precise manufacturing Reported

Cowie et al. (≈47 authors, incl. Robert A. Freitas Jr. and Ralph C. Merkle), "Atomically precise mechanosynthesis of carbon structures on hydrogenated Si(100) by inverted-mode STM", arXiv:2605.27250 (May 2026). EAOGe-C₂I molecules act as both imaging probes and reagents, donating C₂ units to pre-patterned reactive sites; the team shows single-site donation, spatially patterned multi-site donation, and stepwise polyyne growth via successive C–C bond formation. Why it matters: moves additive mechanosynthesis from simulation/roadmap to a benchtop demonstration of controlled, site-specific covalent assembly — long the field's central gap. Preprint, not yet peer-reviewed; reproducibility and yield/throughput remain open.

Structural DNA nanotechnology Demonstrated

NYU DNA Lab (Vecchioni and colleagues, building on Seeman's legacy), Nature Communications, Mar 2026. DNA tiles assemble into a library of 3D structures — including mixed right/left-handed "mirror" DNA — guided by the flat helix-end interfaces and subunit geometry rather than sticky-end hydrogen bonding. Why it matters: decouples 3D DNA assembly from sequence-encoded base pairing, opening a shape-programmable design axis and potentially more robust/condition-tolerant assembly.

De novo protein design / engineered nanomachines

Antibodies Demonstrated — Bennett, Watson, Ragotte et al. (IPD), Nature 649:183–193 (2026). Fine-tuned RFdiffusion + yeast display yields VHHs, scFvs and full antibodies binding specified epitopes; binding poses confirmed by cryo-EM (influenza HA, C. difficile TcdB). Why it matters: atomic-accuracy design of the historically hard CDR loops; a concrete AI-driven path to bespoke binders.

Protein cages Reported — Baker lab, "programming proteins with viral geometry" (May 22, 2026). Designed subunits self-assemble into large cages by combining pentagonal and hexagonal patterns, the strategy natural viruses use to close a shell. Why it matters: a route to large, defined protein compartments (delivery, nanoreactors) from first principles. Confirm peer-review status next run.

Synthetic molecular machines Reported

Kluifhooft et al., "A Molecular Machine Directs the Synthesis of a Rotaxane", Angew. Chem. Int. Ed. (2026). A unidirectional motor embedded in a dumbbell axle winds an attached strand into a double-helix-like shape, forming the interlock without preorganization or templating. Why it matters: generalizes machine-directed construction of mechanically interlocked molecules (companion to Leigh's 2025 catenane work, which is outside this window). Single-source/new method — generality across larger or more complex topologies is unproven.

3. New commercial activity

CompanyWhat they doStage / fundingThis period's updateTier
AnthrogenAI foundation models over protein sequence/structure to generate novel molecular machines with atomic-level precision (function-to-sequence)Early-stage startupSurfaced as an active atomic-precision protein-design entrant; specifics of funding/round unverifiedReported
ArchonProtein-design therapeutics (David Baker–lineage); antibody cages$20M seed + $7M grantsRunway into 2026; planning lead-program selection and a follow-on round toward a clinical trialReported
Commercial signal this period is thin and partly carried over from 2025 announcements. Treat funding figures as single-source until confirmed; no verified new rounds, M&A, or spinouts specific to atomic-precision MNT were found within the window.

4. New institutional / policy items

Nothing material verified within the window. (Context, not new: APM continues to be positioned for quantum-device fabrication, claimed as more precise than leading-edge e-beam lithography — a roadmap/Projected framing, not a result.)

5. Quiet areas (checked, nothing notable this period)

6. Sources